“I don’t know what I’ll find in there. It could be cancer. In the best case, you’ll be stuck with a bag for the rest of your life.” Those are the words Paweł Grabowski, a fit and health-conscious 48-year-old from…
Once solely engaged as participants in academic studies and research, patients are increasingly becoming more involved at several stages of the research process. From helping large organisations assess grants and…
“I had very severe symptoms. I had jaundice, I had itching – symptoms that could definitely indicate something related to the liver, or quite severe disease – but because of…
Treatment with the second-generation Bruton tyrosine kinase (BTK) inhibitor acalabrutinib plus the BCL2 inhibitor venetoclax (with or without the CD20 inhibitor obinutuzumab), delivered as fixed-duration therapies, significantly improved progression free survival in comparison with standard-of-care chemotherapy in previously untreated patients…
We'll keep you informed of the latest features and news with a fortnightly email
“I feel I’m among friends… we are all fighting the same battles.” This is how the former European Health Commissioner Stella Kyriakides greeted her audience at the European Cancer Summit at a session on November 20th devoted to her great…
Cancerworld is published by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net
Input your search keywords and press Enter.